ci report adj ep well ahead opco/street
adjust result exclud realiz gain amort
transaction-rel cost beat larg driven global healthcar
segment profit vs opco/street driven primarili
commerci mcr vs opco/street follow quarter
conserv rais ep guidanc
health account almost increas segment profit
result rais ep estim
segment result healthcar earn y-i beat opco/
street estim driven larg commerci
bp y-i opco/street govern bp y-i
soft vs opco
guidanc rais conserv pass
out-performance outlook rais ep guidanc
health account almost
increas segment profit driven
govern segment mcr bp also tweak global-supp
earn maintain group earn
posit commerci growth trend manag posit
commerci perform driven strong growth risk membership
sequenti specif within select group y-i
sequenti although commerci mcr handili beat expect
compani maintain outlook metric appear due earli
year conservat given substant season chang note
expressscript deal reason re-hash reiter motiv
acquir expressscript driven mid-teen ep accret ex-transit
contract revenu synergi furthermor deal posit
core select/middle-market segment provid custom integr
offer lower cost last believ esrx strong margin remain
sustain due contract mix peer diversifi servic offer
conclus overal ci produc anoth qualiti quarter oper trend
remain favor sinc market continu ignor signific financi
benefit acquisit would continu long-term buyer
provid health care relat
benefit us intern
compani offer insur self-
health vision plan well
disabl life insur product
analyst certif import disclosur see disclosur
capit deploy contribut moder growth
medicar busi growth margin acceler
expos strong growth area healthcar
also avoid mani risk minim exposur
small-group individu market rel concentr
aso busi compani also strong track record
growth recent year tradit trade discount
peer although posit neg
express script deal believ compani balanc
sheet ripe take leverag result rate stock
guidanc issu updat
signific uptick util
disabl life busi continu face volatil
exchang busi turn materi loss
price target base combin two methodolog dcf valuat base beta
termin growth rate wacc estim ebitda price-to-earnings target
repres ep estim conserv discount group current trade
includ healthcar reform federal/st regul chang cost trend intern busi risk
premium fee
global care benefit expens
healthcar premium
health care benefit expens settlement
premium fee
total benefit expens
premium fee
oper expens revenu
pharmaci cost good sold
total benefit expens
incom attribut non-controlling interest
dilut ep report
premium fee
global care benefit expens
health care benefit expens settlement
total benefit expens
pharmaci cost good sold
total benefit expens
